ICU Medical, Inc. (ICUI): Price and Financial Metrics


ICU Medical, Inc. (ICUI): $215.56

4.38 (+2.07%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ICUI Stock Summary

  • The ratio of debt to operating expenses for Icu Medical Inc is higher than it is for about just 0.3% of US stocks.
  • With a year-over-year growth in debt of -100%, Icu Medical Inc's debt growth rate surpasses just 0% of about US stocks.
  • The volatility of Icu Medical Inc's share price is greater than that of merely 5.96% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to ICUI, based on their financial statements, market capitalization, and price volatility, are CSPI, LNN, SSTK, UCTT, and CCF.
  • Visit ICUI's SEC page to see the company's official filings. To visit the company's web site, go to www.icumed.com.

ICUI Stock Price Chart Interactive Chart >

Price chart for ICUI

ICUI Price/Volume Stats

Current price $215.56 52-week high $236.51
Prev. close $211.18 52-week low $170.57
Day low $208.76 Volume 34,535
Day high $215.58 Avg. volume 120,176
50-day MA $208.32 Dividend yield N/A
200-day MA $198.34 Market Cap 4.57B

ICU Medical, Inc. (ICUI) Company Bio


ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.

ICUI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$215.56$94.39 -55%

We started the process of determining a valid price forecast for Icu Medical Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Icu Medical Inc ranked in the 36th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 55%. As for the metrics that stood out in our discounted cash flow analysis of Icu Medical Inc, consider:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Notably, its equity weight is greater than 96.48% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately only 0% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 59.98% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-56%
1%-56%
2%-55%
3%-55%
4%-54%
5%-54%

ABC, JNJ, NVS, AZN, and AMPH can be thought of as valuation peers to ICUI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


ICUI Latest News Stream


Event/Time News Detail
Loading, please wait...

ICUI Latest Social Stream


Loading social stream, please wait...

View Full ICUI Social Stream

Latest ICUI News From Around the Web

Below are the latest news stories about Icu Medical Inc that investors may wish to consider to help them evaluate ICUI as an investment opportunity.

ICU Medical, Inc. Announces Time of First Quarter 2021 Earnings Conference Call

SAN CLEMENTE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2021 earnings release and conference call. The Company will release its first quarter 2021 results on Thursday, May 6th, 2021 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 6th, 2021. The call can be accessed at (866) 269-4260, conference ID 5252105. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Inve...

Yahoo | April 15, 2021

ICU Medical, Inc. (NASDAQ:ICUI) Shares Could Be 26% Above Their Intrinsic Value Estimate

Does the March share price for ICU Medical, Inc. ( NASDAQ:ICUI ) reflect what it's really worth? Today, we will...

Yahoo | March 26, 2021

ICU Medical, Inc. to Participate in Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:45 a.m. PT (10:45 a.m. ET) on Tuesday, March 23, 2021. The fireside chat will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay. About ICU Medical, Inc. ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion th...

Yahoo | March 18, 2021

Cardiac Output Monitor Market Trend to 2027 GE Healthcare, Getinge AB, Edward LifeSciences Corporation, Baxter International, Inc., LIDCO Group, Plc., ICU Medical, Inc

Cardiac Output Monitor Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and

OpenPR | March 4, 2021

ICU Medical (NASDAQ:ICUI) Posts Quarterly Earnings Results

ICU Medical (NASDAQ:ICUI) issued its quarterly earnings data on Thursday. The medical instruments supplier reported $1.77 EPS for the quarter, beating the Zacks’ consensus estimate of $1.51 by $0.26, MarketWatch Earnings reports. ICU Medical had a net margin of 6.43% and a return on equity of 9.73%. ICU Medical updated its FY 2021 After-Hours guidance […]

Transcript Daily | February 28, 2021

Read More 'ICUI' Stories Here

ICUI Price Returns

1-mo 3.92%
3-mo -1.01%
6-mo 11.05%
1-year 0.08%
3-year -14.20%
5-year 109.14%
YTD 0.50%
2020 14.63%
2019 -18.51%
2018 6.31%
2017 46.59%
2016 30.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.2036 seconds.